Hot Investor Mandate 1: China Fund Invests In Age-Related Diseases

25 Feb

A China-based investment firm has raised 2 funds to date and has recently closed its second fund in 2015. The firm invests at various stages—typically investing in Series A rounds or later. The firm is able to invest anywhere from USD 500K or more per company, and is flexible with the investment size depending on the deal. The firm has no set number of allocations it plans to make, but could invest in as many as 5-10 companies in the next 12 months. The firm both leads and coinvests. The firm invests globally, and is actively looking for new investment opportunities.

The firm invests in innovative medical technologies and digital health. In medtech, the firm is generally opportunistic in terms of the class of device and therapeutic areas. However, the firm is more interested in devices for cardiovascular and aging related diseases such as hypertension, Alzheimer’s, diabetes, etc; cosmetic devices; and sports medicine/rehabilitation. The device needs to target a high unmet medical need in China. The firm is interested in clinical to on-the-market products. The firm looks for POC therapeutics and devices, preferably with regulatory approval.

The firm may obtain a BOD seat depending on the opportunity. The firm is looking for companies with an exit strategy within 5 years post investment. The firm has the knowledge and know-how to help portfolio companies bring their respective products into the Chinese market.

If you are interested in more information about this investor and other investors tracked by LSN, please email

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: